[Decade of Hodgkin lymphoma: PET CT vs biopsy in single Academic Chilean Center].

Introduction: Hodgkin Lymphoma (HL) is a prevalent hematological cancer in the world and Chile.

Objectives: Show the experience of 10 years treating HL in a Chilean academic center. Additionally, it exposes the diagnostic performance of PET CT and Bone Marrow Biopsy.

Material And Methods: We conducted a retrospective cohort study to collect data and outcomes of patients treated in our center.

Results: 82 patients were analyzed (Average age, 35 years old; the ratio between men and women was 1.9:1). Progression-free survival was 88.6% and 66.4% for localized and advanced stages, respectively. PET as a staging strategy had better sensitivity than Marrow Biopsy.

Conclusions: The clinical results of the patients treated in this Chilean teaching center were comparable to the international literature. Additionally, PET CT proved to be a superior tool in diagnosis and staging compared to biopsy in our patients.